XMAG - ETF AI Analysis
Top Page
Defiance Large Cap ex-Mag 7 ETF (XMAG)
Rating:72Outperform
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, showing solid overall momentum.
Leading Large-Cap Holdings
Several top positions in major technology, financial, health care, and energy companies have shown strong or steady performance, helping support the fund’s returns.
Broad Sector Diversification
Holdings spread across many sectors, including technology, financials, health care, industrials, consumer stocks, energy, and utilities, help reduce the impact of weakness in any single industry.
Negative Factors
Recent Short-Term Weakness
The ETF has slipped over the past month, which may signal near-term volatility or cooling momentum.
Underperforming Key Holdings
Some notable positions, such as Berkshire Hathaway and Walmart, have shown weak or negative performance this year, which can drag on overall returns.
High U.S. Market Concentration
The fund is almost entirely invested in U.S. companies, offering very limited geographic diversification and making it sensitive to U.S.-specific market and economic risks.
XMAG vs. SPDR S&P 500 ETF (SPY)
AUM186.24M
RegionNorth America
Expense Ratio0.35%
Beta0.84
IssuerDefiance
Inception DateOct 21, 2024
Dividend Yield0.45%
Asset ClassEquity
Index TrackedBITA US 500 ex-Magnificent 7 Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume67,662
30 Day Avg. Volume91,149
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
30.84Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering492
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XMAG Summary
XMAG is the Defiance Large Cap ex-Mag 7 ETF, which tracks the BITA US 500 ex-Magnificent 7 Index. It invests in many of the biggest U.S. companies but purposely leaves out the seven mega-size tech names that often dominate the market. The fund holds well-known businesses like JPMorgan Chase and Walmart, along with firms from technology, health care, financials, and more. Someone might invest in XMAG to get broad large-company diversification without being overly tied to the biggest tech giants. A key risk is that the ETF can still rise or fall with the overall stock market.
How much will it cost me?The expense ratio for the Defiance Large Cap ex-Mag 7 ETF (XMAG) is 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to exclude the 'Mag 7' tech giants, requiring more oversight and strategy. It’s designed for investors seeking a unique approach to large-cap stocks.
What would affect this ETF?XMAG's focus on excluding the 'Mag 7' tech giants could benefit from a shift in investor sentiment towards diversification and reduced reliance on mega-cap tech stocks. Positive drivers include potential growth in sectors like financials and healthcare, which are significant holdings, and stability from its broad exposure to U.S. large-cap companies. However, negative factors such as rising interest rates could pressure financial stocks, and economic slowdowns might impact consumer-focused sectors like Consumer Defensive and Consumer Cyclical.
XMAG Top 10 Holdings
XMAG is quietly powered by a mix of U.S. chipmakers, banks, and healthcare heavyweights, with semiconductors like Micron rising and helping to set the pace while Broadcom and AMD look a bit mixed and occasionally lose steam. Financial leaders such as JPMorgan and Visa are steadily pulling their weight, and Berkshire Hathaway adds a more measured, long-term ballast. On the defensive side, healthcare names like Eli Lilly, Johnson & Johnson, and AbbVie, plus energy giant Exxon Mobil, are generally rising, giving the fund a diversified, large-cap feel without leaning on the usual mega-cap tech stars.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Broadcom | 2.61% | $4.86M | $1.70T | 6.87% | 76 Outperform | |
| Micron | 2.48% | $4.61M | $1.15T | 673.84% | 79 Outperform | |
| Eli Lilly & Co | 2.26% | $4.21M | $1.08T | 58.05% | 72 Outperform | |
| JPMorgan Chase | 2.22% | $4.14M | $953.33B | 21.83% | 72 Outperform | |
| Advanced Micro Devices | 1.70% | $3.17M | $779.62B | 215.98% | 73 Outperform | |
| Berkshire Hathaway B | 1.63% | $3.04M | $974.25B | 1.25% | 66 Neutral | |
| Johnson & Johnson | 1.56% | $2.90M | $663.28B | 54.25% | 78 Outperform | |
| Exxon Mobil | 1.54% | $2.87M | $655.73B | 45.99% | 74 Outperform | |
| Visa | 1.44% | $2.68M | $700.27B | 9.28% | 70 Outperform | |
| Walmart | 1.09% | $2.04M | $850.02B | 6.60% | 78 Outperform |
XMAG Technical Analysis
Positive
―
Price Trends
25.84
Positive
25.21
Positive
23.96
Positive
Market Momentum
0.03
Positive
49.97
Neutral
49.72
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XMAG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 26.18, equal to the 50-day MA of 25.84, and equal to the 200-day MA of 23.96, indicating a neutral trend. The MACD of 0.03 indicates Positive momentum. The RSI at 49.97 is Neutral, neither overbought nor oversold. The STOCH value of 49.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XMAG.
XMAG Peer Comparison
Comparison Results
Performance Comparison
XMAG
Defiance Large Cap ex-Mag 7 ETF
25.99
4.31
19.88%
IUS
Invesco RAFI Strategic US ETF
―
―
―
CVLC
Calvert US Large-Cap Core Responsible Index ETF
―
―
―
FTQI
First Trust Hedged BuyWrite Income ETF
―
―
―
SPHB
Invesco S&P 500 High Beta ETF
―
―
―
INFO
Harbor PanAgora Dynamic Large Cap Core ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents